Vitamin D receptor (VDR) acts as a transcription factor mediating genomic actions of calcitriol. Our earlier studies suggested that calcitriol induces translocation of cytoplasmic VDR, but the physiologic relevance of this finding remained uncertain. Previous studies demonstrated that the activation function 2 domain (AF-2) plays an essential role in VDR transactivation. To elucidate hormone-dependent VDR translocation and its role, we constructed green fluorescent protein (GFP) chimeras with full-length VDR (VDR-GFP), AF-2-truncated VDR (AF-2del-VDR-GFP), and ligand-binding domain (LBD)-truncated VDR (LBDdel-VDR-GFP). COS-7 cells were transiently transfected with these constructs. Western blot analysis, fluorescent microscopy, and transactivation assays showed that the generated chimeras are expressed and fluoresce and that VDR-GFP is transcriptionally active. After hormone treatment, cytoplasmic VDR-GFP translocated to the nucleus in a concentration-, time-, temperature-, and analog-specific manner. Hormone dose-response relationships for translocation and for transactivation were similar. Truncation of LBD and truncation of AF-2 each abolished hormone-dependent translocation and transactivation. Our data confirm a hormone-dependent VDR translocation, demonstrate that an intact AF-2 domain is required for this translocation, and indicate that translocation is part of the receptor activation process.
The vitamin D receptor (VDR)1 is a member of the steroid/ thyroid superfamily of transcription factors that mediates gene expression in a calcitriol-dependent fashion. The hormonally active form of vitamin D, calcitriol, is the principal regulator of calcium homeostasis and also regulates hormone secretion, immune functions, cell proliferation, and differentiation (1). After ligand binding, VDR undergoes an activation process. The mechanism and the regulatory steps involved in this activation process are under intense investigation. An understanding of these activation steps offers possibilities for selective pharmacological modulation of steroid hormone actions.Recent studies showed that steroid receptor activation involves conformational changes (2, 3), phosphorylation/dephosphorylation (4), interactions with coregulator proteins (2, 5, 6), and dimerization (7). The activation process of the glucocorticoid receptor (GR), androgen receptor, and progesterone receptor also includes a translocation of these receptors from the cytoplasm to the nucleus. For many years, however, VDR has been considered to reside exclusively in the nucleus even without hormone (8, 9). More recently, significant amounts of unliganded VDR was found in the cytoplasm with immunocytology (10, 11) and with fluorescent labeled hormone in living cells (12). These studies also showed a shift from cytoplasm into the nucleus after calcitriol exposure. Nevertheless, subcellular distribution of VDR remained controversial. Dynamic studies were needed in living cells to clarify the intracellular localization of VDR and to investigate the physiologic si...